The plasma levels of PLA2G7, UBR5, APOE, MMP9, STAT5B, and S100A8 emerge as pivotal biomarkers for predicting the evolution from normal cognition to MCI and further degradation to AD. This evidence concerns the gene PLA2G7 and Alzheimer disease.